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ABSTRACT  
Amavata is a disease of chronic joint and body pain, accompanied by a swelling 
of some or all of the synovial joints. These symptoms are typically accompanied 
by stiffness of joints, loss of appetite, indigestion, lack of enthusiasm, feeling of 
heaviness and fever.  
Among Shodhna therapy described in Ayurveda, Virechana is mostly used in the 
disorders originated from vitiated Pitta. Along with this, it is also useful in the 
disorders in which Pitta is associated with Vata or Kapha dosha. It has direct 
effect on the Agni Adhishthan and also works on Kapha and Vata Adhishsthan. 
Thus, it rectify not only Pitta but Vata and Kapha Dosha also.  
A clinical study of 20 registered cases of Amavata revealed that Virechana karma 
is a very effective treatment of Amavata. This study proved the significance of 
Virecana karma on classical symptom of Amavata i.e., Angamarda, Aruchi, 
Trishna, Jwara, Shoth, etc. It reflects that Virechana karma is a potent Shroto-
vishodhna, a good anti-inflammatory and pain relieving in patients of R.A. 
Statistically significant results were found in Morning stiffness (83.02%, 
P<0.001), Swelling (81.67% , P<0.001), Trishna (56%, P<0.001), Aruchi (80.00%, 
P<0.001), Gaurava (85.37% P<0.001) and Apaka (81.39%). This study reveals 
that Virechana therapy is a very effective Panchakarma procedure with potent 
Sroto Shodhana effect to produce good anti- inflammatory and pain reducing 
feature in patients of R.A. 
INTRODUCTION
 Amavata is a disease of chronic joint and body 
pain, accompanied by a swelling of some or all of the 
synovial joints. These symptoms are typically 
accompanied by stiffness of joints, loss of appetite, 
indigestion, a lack of enthusiasm, a feeling of heaviness, 
and fever. If the condition is allowed to progress the pain 
may begin to migrate from one joint to another joint, 
with an intense sting or burning sensation. There may be 
scanty, frequent urination, and sleep may become 
disturbed. The digestion will continue to worsen, with 
bowel irritability and spasm, constipation, nausea and 
vomiting. There may be dizziness or angina, with profuse 
perspiration, extreme stiffness and episodic fainting.  
  The disease Rheumatoid Arthritis resembles 
Amavata of Ayurveda. The disease R.A. is chronic in 
nature and affects mostly the middle aged group. The 
onset is more frequent during 4th and 5th decade of life 
with 80% of patients developing the disease between the 
age of 35 and 50 years. Women are affected 
approximately 3-4 times more than men. Pregnancy is 
often associated with remission of the disease in the last 
trimester with subsequent relapses after delivery. 
 No doubt Morden medicine has got an important 
role to play in overcoming agony of pain, restricted 
movement and disability caused by the articular 
diseases. Simultaneously prolonged use of allopathic 
medicines are not only giving rise to many side effects 
but also produce more serious complications like Gastrc-
Peptic ulcers, Renal failure etc. Shodhana (bio-
purification), Shamana (pacification) and Nidana 
parivarjanam are main principles of treatment for 
disease in Ayurveda. 
  Due to wide spectrum, prevalence, chronicity of 
the disease in the society and lack of effective 
medicament, it was chosen for the study. The line of 
treatment described for the disease as “Langhanam 
Swedanam Tiktham……”3 can be summarized under 
following captions. 
1) Measures to bring Agni to normal state. 
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2) Measures to pacify or removal of Ama. 
3) Measures to regulate vitiated Vata. 
  For the present study on Amavata, as Shodhan 
therapy Virechana Karma was chosen, as mentioned by 
Chakradatta.4 To evaluate the effect of Shodhana Karma 
on Amavata this study was conducted. In addition to the 
joint pain, the patients of Amavata may have other 
symptoms various degree depending upon the severity 
and chronicity of disease i.e., Angamarda, Aruchi, Trishna, 
Alasya, Gaurava, Jwara, Apaka, Angashoonata etc. as 
Samanya Lakshana of Amavata.5  
Virechana Yoga 
 The Contents of Virechana yoga6 taken from 
Sharangdher Samhita Uttarkhand are as follows. 
 1. Trivrita 
 2. Haubeir 
 3. Root of Dhanti 
 4. Saptala 
 5. Katuki 
 6. Root of Satyanashi 
 7. Goumootra as Bhavna dravya 
Materials and Methods 
 20 cases suffering from Amavata were selected 
from O.P.D and I.P.D of Panchakarma of Rishikul Campus, 
Uttarakhand Ayurveda University Haridwar, on the basis 
of a specific proforma prepared according to signs and 
symptoms of Amavata as described in Ayurvedic texts 
and symptoms of Rheumatoid Arthritis. 
A. Inclusion Criteria  
 The diagnosis of these patient was confirmed on 
the basis of recent criteria laid down by “American 
Rheumatism Association(1987)”. 
i. Presence of Morning stiffness  
ii. Arthritis of three or more joints 
iii. Arthritis of hand joints 
iv. Symmetric arthritis 
v. Rheumatoid nodules 
vi. Rheumatoid factor 
vii. Radiographic changes 
viii. Age between 12-60 years. 
ix. Chronicity between 6 weeks to 5 years. 
Presence of minimum of four features with a 
duration of 6 weeks or more was taken as the criteria for 
inclusion. Amavata was diagnosed according to the 
presence of clinical features described in Madhav Nidana 
Chapter (25/6-10). All the patient were examined and 
assessed by detailed history, through clinical 
examination and relevant laboratory investigations to 
establish final diagnosis. 
2. Age between 12-60 years. 
B. Exclusion Criteria 
1. Age below 12 year and more than 60 year. 
2. Patient associated with following extra-articular 
manifestations: 
3. Pleuropulmonary involvement 
4. Sjogren’s Syndrome 
5. Felty’s Syondrome  
6. Neurologic involvement Subluxation or nerve 
entrapment etc.  
7. Any evidence of joint tuberculosis, gout, O.A, 
Arthritis with malignancy, Osteomyelitis, 
Rheumatic fever, Osteoporosis.8 
Criteria of Assessment  
 All the patients registered for the clinical trial 
were selected for their demographic profile like age, sex, 
marital status, Deha and Manas prakriti etc. During the 
trial and follow up study the patients were assessed on 
the following parameters. 
i. Subjective Improvement 
ii. Clinical Improvement 
iii. Functioning Improvement 
iv. Haematological Changes 
v. Radiological Changes 
i. Subjective Improvement 
 Attempts were made to elicit the subjective 
improvements produced by the procedure and drug 
under trial. Patient were specifically asked about 
growing feeling of well being and improvement of joint 
functions. 
ii. Clinical Improvement 
For the assessment of clinical improvement , The 
incident of presenting features were worked out and the 
severity of the symptoms rated in each case. For this 
purpose the following “Symptoms Rating Scale” was used 
in all below mentioned symptoms except number of joint 
involved in which exact number of involved joint were 
noted. In this scale various symptoms are graded into 
different grades as shown below: 
Table 1: Symptoms Rating Scale for Rheumatism 
- Absent  0 
+ Mild 1 
++ Moderate 2 
+++ Severe 3 
++++ Agonizing 4 
 The details of assessments of the symptoms 
studied were as follows: 
1. Morning Stiffness  
0. No Stiffness. 
1. Stiffness lasting for ½ hour or 30 min. 
2. Stiffness lasting for 30 min to 1 hour. 
3. Stiffness lasting for 1 hour to 4 hour. 
4. Stiffness lasting for > 4 hour. 
2. Joint Pain 
0. No pain. 
1. Mid pain of bearable nature, comes occasionally. 
2. Moderate pain but no difficulty in movement of 
joint, appears frequently and requires some 
major for relief. 
3. Severe pain with slight difficulty in joint 
movement, remain throughout day and require 
medication. 
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4. Agonizing pain with more difficulty in joint 
movement, disturbing the sleep and require 
strong analgesics. 
3. Swelling on Joint 
0. No Swelling. 
1. Slight swelling. 
2. Moderate swelling. 
3. Severe swelling with diurnal variation. 
4. Severe swelling without diurnal variation. 
4. Restriction of Movements 
0. No restriction. 
1. Mid restriction with discomfort. 
2. Moderate restriction, activities possible after 
some efforts. 
3. Severe restriction, activities possible after 
maximum efforts. 
4. Total restriction of movements. 
5. Number of Joints Involved  
Exact number of involved Joints was noted in 
these criteria. Each Joint of either side(right or left) was 
counted as a individual Joint. 
6. Diffuse Musculoskeletal Pain (Angamarda) 
0. No musculoskeletal pain. 
1. Occasional musculoskeletal pain but patient is 
able to do work . 
2. Continuous musculoskeletal pain but patient is 
able to do work.  
3. Continuous diffuse musculoskeletal pain which 
hampers routine work. 
4. Due to continuous diffuse musculoskeletal pain 
patient is unable to do any work. 
7.  Anorexia (Aruchi) 
0. Normal desire for food. 
1. Eating timely without much desire. 
2. Desire for food, little late, than normal time. 
3. Desire for food, only after long intervals. 
4. No desire at all. 
8. Thirst (Trishna) 
0. Normal feeling of Thirst. 
1. Frequent feeling of thirst, but quench with 
normal amount of liquids. 
2. Satisfactory quench after increased intake of 
fluids but no awakening during nights. 
3. Satisfactory quench after increased intake of 
fluids with regular awakening during night. 
4. No quench after heavy intake of fluids. 
9. Malaise (Alasya) 
0. No malaise. 
1. Starts work in time with effort. 
2. Unable to start work in time but completes the 
work. 
3. Delay in start of work and unable to complete. 
4. Never able to start the work and always like rest. 
10. Fatigue (Gauravata) 
0. No fatigue. 
1. Occasional fatigue but does usual work. 
2. Continuous fatigue but does usual work. 
3. Continuous fatigue which hampers usual work. 
4. Unable to do any work due to fatigue. 
11. Fever (Jwara) 
0. No fever. 
1. Occasional low grade fever once or twice a 
week. 
2. Occasional fever in range of 99.4○ to 101○ F 
with frequency 3 to 5 times a week. 
3.  Rise in temperature at least once a day. 
4.  Continuous low or high grade fever. 
12. Indigestion (Apaka) 
0. Normal digestion. 
1. Occasional indigestion once or twice a week in 
one meal 
2. Occasional indigestion 3 to 5 times a week in 
one meal. 
3. Indigestion 3 to 5 times a week in both meals. 
4. Indigestion after every meal. 
iii. Functional improvement 
Following method were used in the selected 
patient for the assessment of functional status and to 
assess the pattern of functional recovery: 
a. Grip power: This test represent the functional 
capacity of joint of upper extremities specially the 
smaller joint of hand and wrist. The patients were 
asked to hold the inflated cuff of sphygmomanometer 
in their hands and press it with a grip. The reading 
obtained in mmHg were recorded as grip power. 
b. Pressing power of the hands: This also denotes the 
functional status of hands and wrist joints. The 
patients were asked to press on the inflated cuff of 
sphygmomanometer and the manometer changes 
were recorded in mmHg. 
c. Walking Time: This is the time taken by an 
individual to walk a given distances. It depends upon 
the functional status of knee, ankle, hip and smaller 
joints of feet. Whenever any joint of lower extremities 
is involved, the time taken in covering the same 
distance is increased. In the present study a distance 
of 10 meters was fixed for the purpose.  
d. Functional Index  
Table 2: It is based on following functional rating scale 
0 Fit for all activities – No handicap 
1 Moderate restriction – Independent despite some limitation of joint movement 
2 Mild restriction – limited self care. Some assistance required  
3 Marked Restriction-Very limited self care. More assistance required 
4 Confined to chair or bed bound – Largely incapacitated and dependent 
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Administration of Drug 
 20 clinically diagnosed cases of Amavata (RA) was registered and were subjected for Virechana Karma. 
OBSERVATION AND RESULTS  
Table 3: Effect of Trial on Symptoms 
Parameter B.T. A.T. Diff % S.D S.E. ‘t’ P 
Morning Stiffness 2.65 0.45 2.2 83.02 1.19 0.27 8.2 <.001 
Joint Pain 2.6 1.15 1.45 55.77 0.60 0.14 10.7 <.001 
Swelling of Joints 3 0.55 2.45 81.67 0.99 0.22 10.97 <.001 
Restriction of joint movement 3 1.2 1.8 60 0.52 0.11 15 <.001 
No. Of joints involved 3.7 1.15 2.55 68.92 0.51 0.11 22 <.001 
Diffused musculoskeletal pain 2.85 0.75 2.1 73.68 0.85 0.19 11.02 <.001 
Aruchi 2.8 0.65 2.1 75 0.67 0.15 14 <.001 
Trishna 2.78 1.2 1.56 56 0.53 0.17 8.85 <.001 
Alasya 2.78 1.1 1.7 61.54 0.47 0.12 13.68 <.001 
Gaurava 3.15 0.46 2.7 85.37 0.48 0.13 20.21 <.001 
Jawara 0 0 0 0 0 0 0 <.001 
Apaka 2.39 0.44 1.94 81.39 0.80 0.18 10.28 <.001 
Table 4: Effect of Trial on Functional Changes 
Parameter B.T. A.T. Diff. % S.D. S.E. ‘t’ P 
Grip Power (mm of Hg) Rt. Hand 103.2 174.1 70.9 68.70 17.37 3.88 18.3 <.001 
Lt. Hand 90.6 162.3 71.7 79.14 22.10 4.94 14.5 <.001 
Pressing Power (mm of 
Hg) 
Rt. Foot 13.65 22.35 8.7 63.74 3.6 0.80 10.7 <.001 
Lt. Foot 10.7 15.5 4.8 44.86 2.3 0.51 9.4 <.001 
Walking Time (Sec) 52.55 24.55 28 53.28 7.4 1.7 16.87 <.001 
Functional Index 2.15 0.4 1.75 81.39 0.79 0.17 9.9 <.001 
DISCUSSION 
 Deepan Pachan- Trikatu Churna 3 gms two times a 
day with water was given for 3 days 
 Snehapana with Shunthyadi Ghrita was done for 5-7 
days. 
 Sarvanga Abhyanga and Sarvanga Swedana was 
done for 2 days 
 Virechana yoga was given in the dose of 15-25gm 
with lukewarm water for Virechana Karma  
 After Virechana Karma Sansarjana Karma was done 
for 5 to 7days  
 In the patients highly significant improvement 
was seen in all cardinal and associated symptom of the 
disease Amavata with physical activities. 
CONCLUSION 
  Virechana therapy showed highly significant 
relief in almost all clinical features. Statistically 
significant results were found in morning stiffness 
(83.02%, P<0.001), swelling (81.67% , P<0.001), Trishna 
(56%, P<0.001), Aruchi (80.00%, P<0.001), Gaurava 
(85.37% P<0.001) and Apaka (81.39%). Functional 
assessment parameters has shown highly significant 
improvements.  
 This study reveals that Virechana therapy is a 
very effective Panchakarma procedure with potent Sroto 
Shodhana effect to produce good anti- inflammatory and 
pain reducing feature in patients of R.A. 
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